Form 4: Labcorp Director Converts RSUs to Common Stock

Labcorp Holdings Inc. Director Richelle P. Parham acquired 897 shares of common stock through the vesting of Restricted Stock Units on February 11, 2026.

Summary

• Richelle P. Parham, a Director at Labcorp Holdings Inc. (LH), acquired 897 shares of common stock.
• This acquisition occurred on February 11, 2026, through the full vesting of 897 Restricted Stock Units (RSUs).
• Each RSU represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
• Following this transaction, Ms. Parham directly beneficially owns 3,366 shares of common stock and 773 Restricted Stock Units.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine, slightly positive event, reflecting standard director compensation and a modest increase in direct insider ownership.

Positives

• Increased direct ownership by Director Richelle P. Parham, aligning her interests more closely with those of shareholders.
• The transaction represents a standard, pre-scheduled equity compensation event, indicating stability in executive remuneration practices.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly RSU conversions, are common compensation practices in the healthcare diagnostics industry, reflecting standard executive and director remuneration structures.

Comparison to Industry Standards

• RSU vesting and conversion to common stock is a standard form of equity compensation for directors and executives across various industries, including healthcare.
• This aligns with typical compensation structures seen at peer companies in the diagnostics and laboratory services sector, such as Quest Diagnostics (DGX) or Eurofins Scientific (ERF.PA).

Related Party Transactions

• Acquisition of 897 shares of common stock by Director Richelle P. Parham from Labcorp Holdings Inc. through the vesting of Restricted Stock Units, which is a standard related-party compensation transaction.

Stakeholder Impact

• Shareholders: The transaction increases the director's direct equity stake, potentially enhancing alignment of interests.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

This Form 4 details a routine, pre-scheduled vesting and conversion of Restricted Stock Units for a director, which is a standard component of executive compensation. It does not introduce new material information that would fundamentally alter an investment thesis or warrant a change in recommendation. The transaction reflects a planned event rather than a discretionary market action.

Keywords

Labcorp, LH, Form 4, insider transaction, director, stock acquisition, RSU, restricted stock unit, beneficial ownership